Aiforia has signed a commercial agreement with PathAI to make its artificial intelligence (AI) solutions for digital pathology available to laboratories through PathAIโs AISight Marketplace. The agreement will extend the reach of Aiforiaโs AI models to laboratories using AISight Dx, PathAIโs image management system, with a particular focus on expanding Aiforiaโs presence in the US [โฆ]
The post Aiforia deal to expand access to pathology AI appeared first on Pharmafile.